1The Ocular Surface Institute, College of Optometry, University of Houston, Houston, Texas
Submitted: June 17, 2020
Accepted: April 28, 2021
Funding/Support: National Eye Institute (T35 EY007088) and National Eye Institute (P30 EY07551).
Conflict of Interest Disclosure: No financial support was received from a corporate entity for this study. DAB serves on an advisory board for Visioneering Technologies, Inc. and receives contact lens solution from Bausch + Lomb for a National Institutes of Health–funded clinical trial.
Author Contributions and Acknowledgments: Conceptualization: EMS, DAB; Data Curation: LAH, EMS, DAB; Formal Analysis: LAH, EMS, DAB; Investigation: LAH, EMS, DAB; Methodology: LAH, EMS, DAB; Project Administration: LAH, EMS, DAB; Resources: DAB; Supervision: DAB; Visualization: LAH, EMS, DAB; Writing – Original Draft: LAH, DAB; Writing – Review & Editing: LAH, EMS, DAB.
This study received grant support from the National Institutes of Health/National Eye Institute (T35 EY007088 and P30 EY07551). The authors thank Eric Ritchey, OD, PhD, for his assistance in figure design and Julia Benoit, PhD, for statistical advice.
These data were presented, in part, at the annual meeting of the American Academy of Optometry (Orlando 2019).